| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $113.8M | +37.2% |
| R&D Expense | $20.7M | -13.7% |
| SG&A Expense | $77.8M | +1209.8% |
| Operating Income | -$88.2M | -1384.7% |
| Interest Expense | $95.7M | +47.7% |
| Pre-tax Income | -$221.5M | -88.8% |
| Income Tax | -$3.3M | +58.8% |
| Net Income | -$218.3M | -5869.4% |
| EPS (Basic) | -$3.68 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.4M | +9669.3% |
| Accounts Receivable | $14.9M | +33.4% |
| Current Assets | $86.0M | +7858.9% |
| Total Assets | $433.2M | +145.9% |
| Current Liabilities | $62.1M | +1227.6% |
| Long-term Debt | $162.0M | -51.1% |
| Total Liabilities | $288.5M | +846.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$72.6M | -6952.9% |
| Investing Cash Flow | -$10.2M | +79.2% |
| Financing Cash Flow | $111.5M | +6668.2% |
| +81.4% |
| EPS (Diluted) | -$3.68 | +81.4% |
| Stockholders' Equity |
| $144.7M |
| +593.7% |